Abstract:Abstract Metabolomic analysis is a technology which seeks to provide a comprehensive profile of all the metabolites present in a biological sample ( Fiehn 2002 ; Noguchi et al. 2003 ; Watkins et al. 2002 ). Metabolomics is not a new science, but emerging as an exciting application which can span the scope of biotechnology and medicine, providing metabolic profile and a complement to the genomic and proteomic data ( German et al. 2003 ). Studies have already begun to explore the effects of toxicological, pharmaceutical, nutritional, and environmental intervention and to build integrated databases of metabolite concentrations throughout biological systems, ranging from microbes to plants to human and research animal populations ( Bruskiewich et al. 2003 ; Bailey et al. 2003 ; Fiehn 2003 ; Novotna et al. 2003 ). This may provide a tool for discovering a novel pathway, or determining the relationship of these metabolite concentrations to disease, and the extent to which nutrition can modulate metabolite concentrations ( Weckwerth and Fiehn 2002 ). Metabolites are the products of enzymatic processes. Their levels can be regarded as the ultimate response of biological systems to genetic or environmental changes ( Fiehn 2002 ). While the amount of an enzyme protein in a biological system could be quantified by using specific antibodies or by measuring the mRNA responsible for their production, factors such as the availability of cofactors and coenzymes, feedback regulation, pH, compartmentalization, etc. could affect their activity, thus, in turn, affect the metabolite's (i.e., substrates and their enzymatic products) levels. There have been a number of different interpretations of "metabolites." In pharmacological and toxicological studies, metabolites could be considered as the enzymatic degradative products of drugs ( Nishikawa et al. 2003 ; Plumb et al. 2002 ; Reo 2002 ; Robosky et al. 2002 ; Slim et al. 2002 ). In other studies, metabolites could be referred to as amino acids ( Noguchi et al. 2003 ), keto acids ( Bailey et al. 2003 ), or lipids ( German et al. 2003 ), which are substrates and products of selected metabolic pathways. Noguchi et al. (2003) proposed using "subset" to indicate the type of metabolites to be studied. Thus, the amino acid subset, for example, would indicate the levels of all the amino acids in a sample and lipomic subset would indicate the levels of all metabolites involved in lipid metabolism. In biochemical, physiological, and toxicological studies, animal models are preferred. In fact, a large amount of information on metabolites balance has been accumulated for a number of pharmacological, toxicological, and pathological conditions ( Henry et al. 1985 ; Needleman et al. 1968 ; Tourtellotte et al. 1966 ; McDougal, Jr. et al. 1997 ; Yang et al. 1985 ; King et al. 1967 ; Lowry et al. 1983 ; Gupta et al. 2000 ; Gupta et al. 2001a ,b; Gupta and Dettbarn 2003). Only recently has attention been directed towards studying metabolites in cell culture. Cell culture, with intact membrane and cytoplasmic organelles that operate under well understood biochemical and molecular events, provides a simple model that is best used for studying the basic mechanisms of toxicological and pharmacological actions of xenobiotics. Other advantages of using cell culture are to lighten the heavy workload and complications involved in performing animal studies, as well as to reduce the use of animals, which is also advocated on the ground of good animal ethics. To correlate the results in vivo, the data need to be transformed taking into consideration the level of toxicant at the site of action.

Stable Isotope-Assisted Metabolomics for Deciphering Xenobiotic Metabolism in Mammalian Cell Culture

Synergy Between Experiments and Computations: A Green Channel for Revealing Metabolic Mechanism of Xenobiotics in Chemical Toxicology

A broad, exposome-type evaluation of xenobiotic phase II biotransformation in human biofluids by LC-MS/MS

Elucidation of xenoestrogen metabolism by non-targeted, stable isotope-assisted mass spectrometry in breast cancer cells

High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization.

Liquid Chromatography-Mass Spectrometry in Studies of Drug Metabolism and Permeability

NMR-based metabolomics of mammalian cell and tissue cultures

An Integrated Hepatocyte Stability Assay for Simultaneous Metabolic Stability Assessment and Metabolite Profiling

Identifying xenobiotic metabolites with in silico prediction tools and LCMS suspect screening analysis

Integrating in vitro metabolomics with a 96-well high-throughput screening platform

Metabolomics Simultaneously Derives Benchmark Dose Estimates and Discovers Metabolic Biotransformations in a Rat Bioassay

Production of Human Phase 1 and 2 Metabolites by Whole-Cell Biotransformation with Recombinant Microbes

Analysis of Multiple Metabolomic Subsets In Vitro: Methodological Considerations

Analytical strategies for identifying drug metabolites

The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends

Metabonomics: its potential as a tool in toxicology for safety assessment and data integration

Metabolite fingerprinting: A powerful metabolomics approach for marker identification and functional gene annotation

High-throughput screening of the effects of 90 xenobiotics on the simplified human gut microbiota model (SIHUMIx): a metaproteomic and metabolomic study

Stable Isotope–Assisted Plant Metabolomics: Combination of Global and Tracer-Based Labeling for Enhanced Untargeted Profiling and Compound Annotation

Application of Mass Spectrometry for Metabolite Identification

IsoSearch: an Untargeted and Unbiased Metabolite and Lipid Isotopomer Tracing Strategy from HR-LC-MS/MS Datasets